Alnylam Pharmaceuticals | ALNY - أرباح التشغيل





أرباح التشغيل تغيير تاريخ
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amgen USD 4.61B 777M 2026-06
Arrowhead Research USD -170.09M 28.83M 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Incyte USD 700.4M 376.22M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Moderna USD -815M 573M 2026-06
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Novartis USD 4.24B 171M 2026-03
PTC Therapeutics USD 45.89M 127.51M 2026-03
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sanofi EUR 2.27B 771M 2026-03
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Takeda JPY 201.42B 215.04B 2026-06
Tectonic Therapeutic USD -27.3M 5.78M 2026-03
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06
Xencor USD -36.6M 41.26M 2026-06